secwatch / observer
8-K filed March 19, 2026, 7:59 PM ET ticker TNON CIK 0001560293
earnings confidence high sentiment positive materiality 0.75

Tenon Medical Q4 revenue $1.5M (+92% YoY); full year $3.9M (+20%); FDA clearance for next-gen SI fusion system

Tenon Medical, Inc.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Tenon Medical, Inc. reported full year 2025 results: revenue $3.9 million, net income net loss was $12.6 million, EPS $1.70 per share.

Period
full year 2025
Revenue
$3.9 million
Net income
net loss was $12.6 million
EPS
$1.70 per share
Result
reported results
Exact text from the filing
Fourth Quarter and Full Year 2025 Financial Results ~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~ ~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half Momentum ~ ~ Record Full Year 2025 Gross Profit of $2.4 Million, a 38% Increase Compared to Prior Year ~ ~
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Tenon Medical, Inc. reported fourth quarter 2025 results: revenue $1.5 million, net income net loss was $2.8 million, EPS $0.29 per share.

Period
fourth quarter 2025
Revenue
$1.5 million
Net income
net loss was $2.8 million
EPS
$0.29 per share
Result
reported results
Exact text from the filing
RELEASE OF TENON MEDICAL, INC., DATED MARCH 19, 2026 Exhibit 99.1 Tenon ® Medical Reports Fourth Quarter and Full Year 2025 Financial Results ~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~ ~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half Momentum ~ ~ Record
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Tenon Medical, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-26-031840
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.